Skip to main content
A

ABIGAIL

ABIGAIL is an AI‑powered patent prosecution platform that drafts USPTO Office Action responses by running the input through an 11‑expert analysis pipeline and verifying each output against the source documents with Glass Box transparency. The service handles all major rejection types—including 101, 102, 103, 112, double patenting, and drawing objections—and offers pay‑per‑use pricing, making it suitable for solo practitioners and large firms alike.

Updated 1 month ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Patent practitioners often spend many hours manually analyzing Office Actions, mapping prior art, and drafting claim amendments, which delays response times and increases costs, especially for solo attorneys and small firms lacking extensive resources.

Solution

ABIGAIL is an AI‑native patent prosecution platform that generates claim‑by‑claim Office Action responses in roughly 30 minutes. Its 11‑expert analysis pipeline performs element‑level prior‑art mapping, eligibility assessment, and objection handling across all major rejection types (101, 102, 103, 112, double patenting, drawing objections, restriction requirements). Each output is verified against the source documents through Glass Box transparency, ensuring anti‑hallucination compliance and 37 CFR‑ready DOCX exports. The service integrates USPTO PAIR syncing, deadline alerts, examiner intelligence, and a Prior Art Comparator, all delivered via a pay‑per‑use model with no subscription or seat fees.

Target Audience

Primary users are patent attorneys and agents in solo practices, boutique firms, and larger IP law firms who need fast, accurate Office Action responses and docket management.

Features

  • 11 specialized LLM experts covering eligibility, obviousness, written description, drawing objections, and more
  • Element‑level prior‑art mapping with side‑by‑side comparator and citation verification
  • Glass Box AI transparency that cross‑checks every draft against source documents
  • Automatic generation of 37 CFR‑compliant DOCX exports ready for filing
  • USPTO PAIR synchronization, deadline monitoring, and examiner intelligence dashboards
  • Full docket management including claim tracking, drawing support, and chemical/sequence claim verification
  • OpenClaw REST API for integration into existing workflow tools
  • SOC 2 Type II compliance and secure data handling
This profile is AI-generated and may contain inaccuracies.